Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: KURVELO — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Kurvelo, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Lupin Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KURVELO (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for KURVELO (LEVONORGESTREL AND ETHINYL ESTRADIOL)